Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and #PancreaticCancer 🧪 pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/...
pathsocjournals.onlinelibrary.wiley.com
Recently, we suggested the combination of chemotherapy and P2RX4 inhibition as a promising novel therapeutic approach for P2RX4-expressing epithelial tumors to prevent paracrine resistance. Here, we ...